Medical Food Market to Reach $58.9 Billion by 2035

The Global Medical Food Market was valued at $29.5 billion in 2025 and is projected to reach $58.9 billion by 2035, expanding at a CAGR of 7.2% during the forecast period. The market growth is primarily driven by the rising global burden of chronic and metabolic disorders, which is increasing the demand for specialised nutritional therapies designed for disease management. A key macro driver influencing the market is the growing prevalence of chronic diseases worldwide. According to the World Health Organisation (WHO), noncommunicable diseases (NCDs) account for approximately 74% of global deaths annually, with conditions such as diabetes, cardiovascular diseases, and cancer leading the burden. Additionally, data from the International Diabetes Federation (IDF) indicates that over 537 million adults were living with diabetes globally in 2021, a figure expected to rise significantly by 2030. This increasing patient population requires clinically formulated nutrition solutions, thereby driving demand for medical foods across hospitals and home care settings.

Browse the full report description of “Medical Food Market Size, Share & Trends Analysis Report, By Product Type (Oral Medical Foods, Enteral Medical Foods, and Specialized Formulas), By Application (Metabolic Disorders, Neurological Disorders, Gastrointestinal Disorders, Diabetes & Cardiometabolic Support, Orphan & Rare Disorders, and Oncology Nutrition Support), By Formulation Type (Amino Acid-based, Fat-based, Carbohydrate-modified, Protein-restricted, Fiber-enriched, Ketogenic), and By Distribution Channel (Hospital Pharmacy, Retail Pharmacy, and Online Pharmacies), Forecast Period (2026–2035)” at https://www.omrglobal.com/industry-reports/medical-food-market

Among product types, oral medical represents the fastest-growing segment due to convenience, improved patient compliance, and rising adoption in outpatient care. RTD formats are widely used in oncology nutrition support, geriatric care, and chronic disease management due to ease of administration and precise nutrient composition. The convergence of rising disease prevalence, increasing healthcare awareness, and innovation in specialized nutritional formulations is expected to significantly drive the global medical food market over the coming decade. Market players are actively adopting strategic initiatives to strengthen their market position. For instance

• In January 2026, Nestle Health Science launched a large-scale clinical research initiative focused on understanding the impact of lifestyle and nutrition on gut health, strengthening its scientific capabilities in medical nutrition and personalised dietary solutions.

• In November 2025, Abbott Laboratories launched a new and advanced formulation of Ensure Diabetes Care, a clinically proven medical nutrition product designed to support blood glucose control, weight management, and overall metabolic health.

Market Coverage

• The market number available for – 2025-2035
• Base year- 2025
• Forecast period- 2026-2035
• Segment Covered-

o Product Type

o Distribution Channel

o Application

o Formulation Type

• Competitive Landscape - Nestle health science, abbot laboratories, Danone (Nutrica Version), Fresenius Kabi AG, Reckitt Benckiser

Key questions addressed by the report.

• What is the market growth rate?
• Which segment and region dominate the market in the base year?
• Which segment and region will project the fastest growth in the market?
• Who is the leader in the market?
• How are players addressing challenges to sustain growth?
• Where is the investment opportunity?

Global Medical Food Market Report Segment

By Product Type

• Oral Medical Foods
  o Powder formulations
  o Ready-to-drink (RTD) liquids
  o Bars / solid nutritional formats
  • Enteral Medical Foods
  o Tube feeding formulas
  o Specialised liquid enteral nutrition
  • Specialised Formulas
  o Amino acid-based formulas
  o Ketogenic medical foods
  o Elemental / semi-elemental diets

By Application

• Metabolic Disorders
  o PKU (Phenylketonuria)
  o Maple syrup urine disease (MSUD)
  o Urea cycle disorders
  • Neurological Disorders
  o Alzheimer’s disease
  o Epilepsy (ketogenic therapy)
  • Gastrointestinal Disorders
  o IBS (irritable bowel syndrome)
  o Crohn’s disease
  o Short bowel syndrome
  • Diabetes & Cardiometabolic Support
  • Orphan / Rare Genetic Disorders
  • Oncology Nutrition Support

By Formulation Type

• Amino Acid-based
  • Fat-based (MCT / LCT optimised)
  • Carbohydrate-modified formulas
  • Protein-restricted formulations
  • Fibre-enriched medical foods
  • Ketogenic ratio-based formulas

By Distribution Channel

• Hospital Pharmacy
  • Retail Pharmacy
  • Online Pharmacies / E-commerce

Global Medical Food Market Report Segment by Region

North America

• United States
  • Canada

Europe

• UK
  • Germany
  • Italy
  • Spain
  • France
  • Russia
  • Rest of Europe

Asia-Pacific

• China
  • India
  • Japan
  • South Korea
  • Australia and New Zealand
  • ASEAN Economies
  • Rest of Asia-Pacific

Rest of the World

• Latin America
  • Middle East & Africa

To learn more about this report request a sample copy @ https://www.omrglobal.com/request-sample/medical-food-market